Total Payments
$898.22
2024 Payments
$108.19
Companies
11
Transactions
43
Medicare Patients
406
Medicare Billing
$38,877
Payment Breakdown by Category
Food & Beverage$898.22 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $898.22 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $259.24 | 11 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $164.45 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $159.95 | 10 | $0 (2024) |
| ABBVIE INC. | $97.07 | 3 | $0 (2024) |
| Alkermes, Inc. | $77.27 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.12 | 3 | $0 (2021) |
| Allergan Inc. | $24.50 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $21.19 | 1 | $0 (2018) |
| ITI, Inc. | $19.07 | 1 | $0 (2021) |
| Lundbeck LLC | $17.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.19 | 4 | ABBVIE INC. ($60.14) |
| 2023 | $23.43 | 1 | AbbVie Inc. ($23.43) |
| 2022 | $86.63 | 4 | Neurocrine Biosciences, Inc. ($27.34) |
| 2021 | $81.07 | 5 | Neurocrine Biosciences, Inc. ($32.16) |
| 2020 | $109.51 | 6 | Janssen Pharmaceuticals, Inc ($40.79) |
| 2019 | $276.97 | 11 | Neurocrine Biosciences, Inc. ($115.12) |
| 2018 | $143.64 | 8 | Otsuka America Pharmaceutical, Inc. ($50.22) |
| 2017 | $68.78 | 4 | Otsuka America Pharmaceutical, Inc. ($37.70) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $60.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neuroscience | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Neuroscience | ||||||
| 02/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $27.34 | General |
| Category: Neuropsychiatry | ||||||
| 12/08/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: CNS | ||||||
| 11/16/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: NEUROLOGY | ||||||
| 10/13/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Neuroscience | ||||||
| 03/10/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: PSYCHIATRY | ||||||
| 02/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: NEUROLOGY | ||||||
| 09/01/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Neuroscience | ||||||
| 08/20/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROLOGY | ||||||
| 02/27/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Neuroscience | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neuroscience | ||||||
| 10/24/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: CNS | ||||||
| 10/23/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 43 | $5,246 | $3,176 |
| 2022 | 3 | 61 | 241 | $22,565 | $15,417 |
| 2021 | 4 | 149 | 240 | $19,522 | $11,696 |
| 2020 | 1 | 169 | 313 | $20,226 | $8,588 |
Total Patients
406
Total Services
837
Medicare Billing
$38,877
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 29 | $2,272 | $1,670 | 73.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $2,975 | $1,506 | 50.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 176 | $13,283 | $9,362 | 70.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 32 | $6,799 | $4,292 | 63.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 33 | $2,483 | $1,763 | 71.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 135 | $8,724 | $3,827 | 43.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 68 | $5,132 | $3,788 | 73.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 21 | $4,462 | $3,192 | 71.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 16 | $1,204 | $889.92 | 73.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 169 | 313 | $20,226 | $8,588 | 42.5% |
About Dr. George Strickland, M.D
Dr. George Strickland, M.D is a Psychiatry healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831184480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Strickland, M.D has received a total of $898.22 in payments from pharmaceutical and medical device companies, with $108.19 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($898.22).
As a Medicare-enrolled provider, Strickland has provided services to 406 Medicare beneficiaries, totaling 837 services with total Medicare billing of $38,877. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Lawton, OK
- Active Since 09/20/2005
- Last Updated 03/25/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1831184480
Products in Payments
- INGREZZA (Drug) $259.24
- REXULTI (Drug) $149.98
- INVEGA SUSTENNA (Drug) $146.67
- VRAYLAR (Drug) $121.57
- ARISTADA (Drug) $77.27
- CAPLYTA (Drug) $34.63
- ABILIFY MAINTENA (Drug) $32.27
- TRINTELLIX (Drug) $24.73
- LATUDA (Drug) $21.19
- VYVANSE (Drug) $17.39
- INVEGA TRINZA (Drug) $13.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lawton
Dr. Francis Armendariz, M.d, M.D
Psychiatry — Payments: $1,117
Psychiatry $1,117
Zoobia Mirza, Do, DO
Psychiatry — Payments: $690.37
Psychiatry $690.37
Mr. William Davies, Md, MD
Psychiatry — Payments: $27.25
Psychiatry $27.25
Dr. Masooda Burki, Md, MD
Psychiatry — Payments: $23.23
Psychiatry $23.23
Dr. Jenny Boyer, Md, MD
Psychiatry
Psychiatry
Dr. Giuseppe Caccioppoli, Md, MD
Psychiatry
Psychiatry